Albert David Ltd.

Financial

	Albert David	Fredun Pharma	Medicamen Biotech
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.84 %	n/a	n/a
Financials
5 yr Average ROE	11.47 %	8.53 %	8.49 %
5yr average Equity Multiplier	1.63	3.02	1.47
5yr Average Asset Turnover Ratio	0.62	1.01	0.58
5yr Avg Net Profit Margin	11.31 %	2.89 %	10.0 %
Price to Book	1.27	3.36	2.45
P/E	28.98	20.28	73.38
5yr Avg Cash Conversion Cycle	-77.77 Days	137.13 Days	13.14 Days
Inventory Days	47.91 Days	140.46 Days	66.66 Days
Days Receivable	27.87 Days	52.11 Days	122.66 Days
Days Payable	140.35 Days	131.93 Days	257.34 Days
5yr Average Interest Coverage Ratio	93.73	2.31	10.36
5yr Avg ROCE	14.69 %	16.75 %	12.12 %
5yr Avg Operating Profit Margin	9.55 %	8.32 %	16.84 %
5 yr average Debt to Equity	0.02	0.86	0.14
5yr CAGR Net Profit	-4.92 %	52.4 %	-6.51 %
5yr Average Return on Assets	7.03 %	3.05 %	5.75 %
Shareholdings
Promoter Holding	62.24 %	48.93 %	40.46 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.25 %	-2.11 %	-3.14 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Albert David	Fredun Pharma	Medicamen Biotech
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 0 Pharmaceuticals Formulations 0	Product Wise Break-Up Pharmaceuticals Formulations 0 Pharmaceutical 0 Pharmaceutical 100.0	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Pharmaceutical 0 0
Location Wise Break-Up	Location Wise Break-Up India 93.24 Rest of the World 6.76	Location Wise Break-Up Rest of the World 22.32 India 77.22 Others 0.46	Location Wise Break-Up Rest of the World 0 India 20.0 Others 80.0
Dosage Form Break-Up	Dosage Form Break-Up LVP – Large volume Parenteral 27.91 Syrup 21.16 Tablet 15.97 SVP – Small volume Parenteral 14.95 Capsule 9.65 Ointment 9.06 Others 1.3	-	-
Customer Wise Break-Up	Customer Wise Break-Up Non Government 98.36 Government 1.64	-	-